Variability of Two Metabolomic Platforms in CKD

BACKGROUND AND OBJECTIVES: Nontargeted metabolomics can measure thousands of low-molecular-weight biochemicals, but important gaps limit its utility for biomarker discovery in CKD. These include the need to characterize technical and intraperson analyte variation, to pool data across platforms, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin J Am Soc Nephrol
Autors principals: Rhee, Eugene P., Waikar, Sushrut S., Rebholz, Casey M., Zheng, Zihe, Perichon, Regis, Clish, Clary B., Evans, Anne M., Avila, Julian, Denburg, Michelle R., Anderson, Amanda Hyre, Vasan, Ramachandran S., Feldman, Harold I., Kimmel, Paul L., Coresh, Josef
Format: Artigo
Idioma:Inglês
Publicat: American Society of Nephrology 2019
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6364529/
https://ncbi.nlm.nih.gov/pubmed/30573658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07070618
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars